Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 54

1.

Neighborhood Socioeconomic Status and Health Care Costs: A Population-Wide Study in the Netherlands.

de Boer WIJ, Buskens E, Koning RH, Mierau JO.

Am J Public Health. 2019 Jun;109(6):927-933. doi: 10.2105/AJPH.2019.305035. Epub 2019 Apr 18.

PMID:
30998412
2.

SPRINTT and the involvement of stakeholders: strategy and structure.

Le Lain R, Ignaszewski C, Klingmann I, Cesario A, de Boer WI; SPRINTT Consortium.

Aging Clin Exp Res. 2017 Feb;29(1):65-67. doi: 10.1007/s40520-016-0706-3. Epub 2017 Jan 31. Review.

PMID:
28144912
3.

Physical Activity Characteristics across GOLD Quadrants Depend on the Questionnaire Used.

Demeyer H, Gimeno-Santos E, Rabinovich RA, Hornikx M, Louvaris Z, de Boer WI, Karlsson N, de Jong C, Van der Molen T, Vogiatzis I, Janssens W, Garcia-Aymerich J, Troosters T, Polkey MI; PROactive consortium.

PLoS One. 2016 Mar 14;11(3):e0151255. doi: 10.1371/journal.pone.0151255. eCollection 2016.

4.

The PROactive instruments to measure physical activity in patients with chronic obstructive pulmonary disease.

Gimeno-Santos E, Raste Y, Demeyer H, Louvaris Z, de Jong C, Rabinovich RA, Hopkinson NS, Polkey MI, Vogiatzis I, Tabberer M, Dobbels F, Ivanoff N, de Boer WI, van der Molen T, Kulich K, Serra I, Basagaña X, Troosters T, Puhan MA, Karlsson N, Garcia-Aymerich J; PROactive consortium.

Eur Respir J. 2015 Oct;46(4):988-1000. doi: 10.1183/09031936.00183014. Epub 2015 May 28.

5.

The PROactive innovative conceptual framework on physical activity.

Dobbels F, de Jong C, Drost E, Elberse J, Feridou C, Jacobs L, Rabinovich R, Frei A, Puhan MA, de Boer WI, van der Molen T, Williams K, Pinnock H, Troosters T, Karlsson N, Kulich K, Rüdell K; PROactive consortium; PROactive consortium.

Eur Respir J. 2014 Nov;44(5):1223-33. doi: 10.1183/09031936.00004814. Epub 2014 Jul 17.

6.

Nitric oxide donors augment interleukin-1β-induced vascular endothelial growth factor in airway smooth muscle cells.

Sharma HS, Alagappan VK, Willems-Widyastuti A, Mooi WJ, de Boer WI.

Cell Biochem Biophys. 2013 Nov;67(2):247-54. doi: 10.1007/s12013-013-9773-7.

PMID:
24142467
7.

Angiogenesis and vascular remodeling in chronic airway diseases.

Alagappan VK, de Boer WI, Misra VK, Mooi WJ, Sharma HS.

Cell Biochem Biophys. 2013 Nov;67(2):219-34. doi: 10.1007/s12013-013-9713-6. Review.

PMID:
23975597
8.

Azithromycin attenuates fibroblast growth factors induced vascular endothelial growth factor via p38(MAPK) signaling in human airway smooth muscle cells.

Willems-Widyastuti A, Vanaudenaerde BM, Vos R, Dilisen E, Verleden SE, De Vleeschauwer SI, Vaneylen A, Mooi WJ, de Boer WI, Sharma HS, Verleden GM.

Cell Biochem Biophys. 2013 Nov;67(2):331-9. doi: 10.1007/s12013-011-9331-0.

PMID:
22205500
9.

Transforming growth factor-beta 1 induces angiogenesis in vitro via VEGF production in human airway smooth muscle cells.

Willems-Widyastuti A, Alagappan VK, Arulmani U, Vanaudenaerde BM, de Boer WI, Mooi WJ, Verleden GM, Sharma HS.

Indian J Biochem Biophys. 2011 Aug;48(4):262-9.

PMID:
22053695
10.

Not more dependency but more self-management for children with asthma.

de Boer WI, Teunissen GJ.

Prim Care Respir J. 2010 Sep;19(3):285. doi: 10.4104/pcrj.2010.00036. No abstract available.

11.

Altered expression of epithelial junctional proteins in atopic asthma: possible role in inflammation.

de Boer WI, Sharma HS, Baelemans SM, Hoogsteden HC, Lambrecht BN, Braunstahl GJ.

Can J Physiol Pharmacol. 2008 Mar;86(3):105-12. doi: 10.1139/y08-004.

PMID:
18418437
12.

Future therapeutic treatment of COPD: struggle between oxidants and cytokines.

de Boer WI, Yao H, Rahman I.

Int J Chron Obstruct Pulmon Dis. 2007;2(3):205-28. Review.

13.

Targeting lung inflammation: novel therapies for the treatment of COPD.

Yao H, de Boer WI, Rahman I.

Curr Respir Med Rev. 2008;4(1):57-68.

14.

Molecular mechanisms in chronic obstructive pulmonary disease: potential targets for therapy.

de Boer WI, Alagappan VK, Sharma HS.

Cell Biochem Biophys. 2007;47(1):131-48. Review.

PMID:
17406066
15.

Tobacco use in relation to COPD and asthma.

Hylkema MN, Sterk PJ, de Boer WI, Postma DS.

Eur Respir J. 2007 Mar;29(3):438-45. Review.

16.

Interleukin-8 stimulates cell proliferation in non-small cell lung cancer through epidermal growth factor receptor transactivation.

Luppi F, Longo AM, de Boer WI, Rabe KF, Hiemstra PS.

Lung Cancer. 2007 Apr;56(1):25-33. Epub 2006 Dec 15.

PMID:
17175059
17.

Enhanced bronchial expression of extracellular matrix proteins in chronic obstructive pulmonary disease.

Kranenburg AR, Willems-Widyastuti A, Moori WJ, Sterk PJ, Alagappan VK, de Boer WI, Sharma HS.

Am J Clin Pathol. 2006 Nov;126(5):725-35.

PMID:
17111536
18.

Expression of epidermal growth factors and their receptors in the bronchial epithelium of subjects with chronic obstructive pulmonary disease.

de Boer WI, Hau CM, van Schadewijk A, Stolk J, van Krieken JH, Hiemstra PS.

Am J Clin Pathol. 2006 Feb;125(2):184-92.

PMID:
16393673
19.

Effects of cigarette smoke condensate on proliferation and wound closure of bronchial epithelial cells in vitro: role of glutathione.

Luppi F, Aarbiou J, van Wetering S, Rahman I, de Boer WI, Rabe KF, Hiemstra PS.

Respir Res. 2005 Nov 25;6:140.

20.

Chronic obstructive pulmonary disease is associated with enhanced bronchial expression of FGF-1, FGF-2, and FGFR-1.

Kranenburg AR, Willems-Widyastuti A, Mooi WJ, Saxena PR, Sterk PJ, de Boer WI, Sharma HS.

J Pathol. 2005 May;206(1):28-38.

PMID:
15772985
21.

Perspectives for cytokine antagonist therapy in COPD.

de Boer WI.

Drug Discov Today. 2005 Jan 15;10(2):93-106. Review.

PMID:
15718158
22.
23.

Human neutrophil defensins and secretory leukocyte proteinase inhibitor in squamous metaplastic epithelium of bronchial airways.

Aarbiou J, van Schadewijk A, Stolk J, Sont JK, de Boer WI, Rabe KF, van Krieken JH, Mauad T, Hiemstra PS.

Inflamm Res. 2004 Jun;53(6):230-8. Epub 2004 May 12.

PMID:
15167969
24.

Growth, differentiation and senescence of normal human urothelium in an organ-like culture.

Daher A, de Boer WI, Le Frère-Belda MA, Kheuang L, Abbou CC, Radvanyi F, Jaurand MC, Thiery JP, Gil Diez de Medina S, Chopin DK.

Eur Urol. 2004 Jun;45(6):799-805.

PMID:
15149756
25.

Epidermal growth factor receptor regulates normal urothelial regeneration.

Daher A, de Boer WI, El-Marjou A, van der Kwast T, Abbou CC, Thiery JP, Radvanyi F, Chopin DK.

Lab Invest. 2003 Sep;83(9):1333-41.

PMID:
13679441
26.

Neutrophil defensins enhance lung epithelial wound closure and mucin gene expression in vitro.

Aarbiou J, Verhoosel RM, Van Wetering S, De Boer WI, Van Krieken JH, Litvinov SV, Rabe KF, Hiemstra PS.

Am J Respir Cell Mol Biol. 2004 Feb;30(2):193-201. Epub 2003 Jul 18.

PMID:
12871849
27.

Potential new drugs for therapy of chronic obstructive pulmonary disease.

de Boer WI.

Expert Opin Investig Drugs. 2003 Jul;12(7):1067-86. Review.

PMID:
12831344
28.

Fully automated assessment of inflammatory cell counts and cytokine expression in bronchial tissue.

Sont JK, De Boer WI, van Schadewijk WA, Grünberg K, van Krieken JH, Hiemstra PS, Sterk PJ; Asthma Management Project University of Leiden Study Group.

Am J Respir Crit Care Med. 2003 Jun 1;167(11):1496-503.

PMID:
12770855
29.

Enhanced expression of fibroblast growth factors and receptor FGFR-1 during vascular remodeling in chronic obstructive pulmonary disease.

Kranenburg AR, De Boer WI, Van Krieken JH, Mooi WJ, Walters JE, Saxena PR, Sterk PJ, Sharma HS.

Am J Respir Cell Mol Biol. 2002 Nov;27(5):517-25.

PMID:
12397010
30.

Functions of epidermal growth factor-like growth factors during human urothelial reepithelialization in vitro and the role of erbB2.

Bindels EM, van der Kwast TH, Izadifar V, Chopin DK, de Boer WI.

Urol Res. 2002 Sep;30(4):240-7. Epub 2002 Jun 7.

PMID:
12202942
31.

4-Hydroxy-2-nonenal, a specific lipid peroxidation product, is elevated in lungs of patients with chronic obstructive pulmonary disease.

Rahman I, van Schadewijk AA, Crowther AJ, Hiemstra PS, Stolk J, MacNee W, De Boer WI.

Am J Respir Crit Care Med. 2002 Aug 15;166(4):490-5.

PMID:
12186826
32.

Human neutrophil defensins induce lung epithelial cell proliferation in vitro.

Aarbiou J, Ertmann M, van Wetering S, van Noort P, Rook D, Rabe KF, Litvinov SV, van Krieken JH, de Boer WI, Hiemstra PS.

J Leukoc Biol. 2002 Jul;72(1):167-74.

PMID:
12101277
33.

Cytokines and therapy in COPD: a promising combination?

De Boer WI.

Chest. 2002 May;121(5 Suppl):209S-218S. Review.

PMID:
12010854
34.

Image analysis and quantification in lung tissue.

De Boer WI, Hiemstra PS, Sont JK, De Heer E, Rabe KF, Van Krieken JH, Sterk PJ.

Clin Exp Allergy. 2001 Mar;31(3):504-8.

PMID:
11260164
35.

Transforming growth factor-beta(1), -beta(2), -beta(3), basic fibroblast growth factor and vascular endothelial growth factor expression in keratinocytes of burn scars.

Hakvoort T, Altun V, van Zuijlen PP, de Boer WI, van Schadewij WA, van der Kwast TH.

Eur Cytokine Netw. 2000 Jun;11(2):233-39.

36.

Localization of gamma-glutamylcysteine synthetase messenger rna expression in lungs of smokers and patients with chronic obstructive pulmonary disease.

Rahman I, van Schadewijk AA, Hiemstra PS, Stolk J, van Krieken JH, MacNee W, de Boer WI.

Free Radic Biol Med. 2000 Mar 15;28(6):920-5.

PMID:
10802223
37.

Monocyte chemoattractant protein 1, interleukin 8, and chronic airways inflammation in COPD.

de Boer WI, Sont JK, van Schadewijk A, Stolk J, van Krieken JH, Hiemstra PS.

J Pathol. 2000 Apr;190(5):619-26.

PMID:
10727989
38.

Regulation of SLPI and elafin release from bronchial epithelial cells by neutrophil defensins.

van Wetering S, van der Linden AC, van Sterkenburg MA, de Boer WI, Kuijpers AL, Schalkwijk J, Hiemstra PS.

Am J Physiol Lung Cell Mol Physiol. 2000 Jan;278(1):L51-8.

39.

Amyloid beta precursor protein-mRNA is expressed throughout cerebral vessel walls.

Natté R, de Boer WI, Maat-Schieman ML, Baelde HJ, Vinters HV, Roos RA, van Duinen SG.

Brain Res. 1999 May 15;828(1-2):179-83.

PMID:
10320740
40.

Expression of transforming growth factor beta1 and its receptors in normal human urothelium and human transitional cell carcinomas.

Izadifar V, de Boer WI, Muscatelli-Groux B, Maillé P, van der Kwast TH, Chopin DK.

Hum Pathol. 1999 Apr;30(4):372-7.

PMID:
10208456
41.

Transforming growth factor beta1 and recruitment of macrophages and mast cells in airways in chronic obstructive pulmonary disease.

de Boer WI, van Schadewijk A, Sont JK, Sharma HS, Stolk J, Hiemstra PS, van Krieken JH.

Am J Respir Crit Care Med. 1998 Dec;158(6):1951-7.

PMID:
9847291
42.

Expression of growth factors and their receptors in adamantinoma of long bones and the implication for its histogenesis.

Bovée JV, van den Broek LJ, de Boer WI, Hogendoorn PC.

J Pathol. 1998 Jan;184(1):24-30.

PMID:
9582523
43.

Chronic obstructive pulmonary disease: role of bronchiolar mast cells and macrophages.

Grashoff WF, Sont JK, Sterk PJ, Hiemstra PS, de Boer WI, Stolk J, Han J, van Krieken JM.

Am J Pathol. 1997 Dec;151(6):1785-90.

44.

Expression and functions of EGF, FGF and TGFbeta-growth-factor family members and their receptors in invasive human transitional-cell-carcinoma cells.

De Boer WI, Houtsmuller AB, Izadifar V, Muscatelli-Groux B, Van der Kwast TH, Chopin DK.

Int J Cancer. 1997 Apr 10;71(2):284-91.

45.

Functions of fibroblast and transforming growth factors in primary organoid-like cultures of normal human urothelium.

de Boer WI, Vermeij M, Diez de Medina SG, Bindels E, Radvanyi F, van der Kwast T, Chopin D.

Lab Invest. 1996 Aug;75(2):147-56.

PMID:
8765315
46.

Expression of growth factors and receptors during specific phases in regenerating urothelium after acute injury in vivo.

de Boer WI, Schuller AG, Vermey M, van der Kwast TH.

Am J Pathol. 1994 Nov;145(5):1199-207.

47.

Characterization of distinct functions for growth factors in murine transitional epithelial cells in primary organotypic culture.

de Boer WI, Rebel JM, Vermey M, de Jong AA, van der Kwast TH.

Exp Cell Res. 1994 Oct;214(2):510-8.

PMID:
7925644
48.

An in vitro model of urothelial regeneration: effects of growth factors and extracellular matrix proteins.

Rebel JM, De Boer WI, Thijssen CD, Vermey M, Zwarthoff EC, Van der Kwast TH.

J Pathol. 1994 Jul;173(3):283-91.

PMID:
7523645
49.

Multiparameter analysis of primary epithelial cultures grown on cyclopore membranes.

De Boer WI, Rebel JM, Vermey M, Thijssen CD, Van der Kwast TH.

J Histochem Cytochem. 1994 Feb;42(2):277-82.

PMID:
7507144
50.

Hyperplasia of epithelium adjacent to transitional cell carcinoma can be induced by growth factors through paracrine pathways.

de Boer WI, Rebel JM, Thijssen CD, Vermeij M, van den Eijnden-Van Raaij AJ, van der Kwast TH.

Virchows Arch. 1994;425(4):439-44.

PMID:
7529622

Supplemental Content

Loading ...
Support Center